XML 17 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jun. 30, 2018
Dec. 31, 2017
Assets    
Cash and cash equivalents $ 132 $ 137
Accounts receivable, net of allowance for doubtful accounts of $11 and $13 as of June 30, 2018 and December 31, 2017, respectively 1,055 924
Inventories 91 95
Prepaid expenses and other current assets 137 150
Total current assets 1,415 1,306
Property, plant and equipment, net 1,168 1,145
Goodwill 6,414 6,335
Intangible assets, net 1,166 1,119
Investment in equity method investees 456 462
Other assets 128 136
Total assets 10,747 10,503
Liabilities and Stockholders' Equity    
Accounts payable and accrued expenses 957 1,021
Current portion of long-term debt 305 36
Total current liabilities 1,262 1,057
Long-term debt 3,408 3,748
Other liabilities 738 663
Commitments and contingencies
Redeemable noncontrolling interest 76 80
Quest Diagnostics stockholders’ equity:    
Common stock, par value $0.01 per share; 600 shares authorized as of both June 30, 2018 and December 31, 2017; 217 and 216 shares issued as of June 30, 2018 and December 31, 2017, respectively 2 2
Additional paid-in capital 2,633 2,612
Retained earnings 7,401 7,138
Accumulated other comprehensive loss (57) (48)
Treasury stock, at cost; 81 shares as of both June 30, 2018 and December 31, 2017 (4,756) (4,783)
Total Quest Diagnostics stockholders' equity 5,223 4,921
Noncontrolling interests 40 34
Total stockholders' equity 5,263 4,955
Total liabilities and stockholders' equity $ 10,747 $ 10,503